Results 41 to 50 of about 21,060 (203)

Evaluation of Medication Risks for Falls on an Inpatient Medical/Surgical Unit [PDF]

open access: yes, 2018
Purpose: Patient falls during hospitalization can delay discharge and decrease quality of life. Medications are one factor that can impact fall risk. This study examines patients who fell while admitted to a cardiac surgery unit to identify which high ...
Zegar, Joseph
core   +1 more source

Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury [PDF]

open access: yes, 2017
BACKGROUND & AIMS: Drug-induced liver injury (DILI) has features similar to those of other liver diseases including autoimmune hepatitis (AIH). We aimed to characterize the clinical and autoimmune features of liver injury caused by nitrofurantoin ...
Chalasani, Naga   +8 more
core   +2 more sources

Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes

open access: yesHemodialysis International, EarlyView.
ABSTRACT Pregnancy in women with end‐stage kidney disease (ESKD) requiring dialysis remains high risk, with significant maternal and fetal complications. While fertility rates are markedly reduced in this population, advances in dialysis care and obstetric management have led to increasing reports of successful pregnancies.
Shreepriya Mangalgi, Silvi Shah
wiley   +1 more source

Studies on the cardiovascular actions of hydralazine.

open access: yesActa Médica Portuguesa, 1979
In conscious normotensive rabbits, the intravenous administration of hydralazine (0.3 mg/Kg) induced a significant decrease of mean arterial blood pressure (MBP) (p 0.05) and did not modify the tachycardia.
Virgílio Durão, Assunção Elvas
doaj   +1 more source

Impact of diabetes mellitus on ventricular structure, arterial stiffness, and pulsatile hemodynamics in heart failure with preserved ejection fraction [PDF]

open access: yes, 2019
Background-Heterogeneity in the underlying processes that contribute to heart failure with preserved ejection fraction (HFpEF) is increasingly recognized.
Akers, Scott R.   +8 more
core   +2 more sources

The Determinants of Negotiated Pharmaceutical Prices

open access: yesThe Journal of Industrial Economics, EarlyView.
ABSTRACT We focus on the determinants of pharmaceutical drug prices. Using data from the Brazilian pharmaceutical market, we find large variations in drug prices across buyers, drug classes, and time periods. Our estimation results provide evidence that transaction‐specific determinants between buyers and sellers (e.g., transaction volume, buyer's ...
Ralph B. Siebert   +2 more
wiley   +1 more source

Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case report

open access: yesJournal of Medical Case Reports, 2020
Background Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure. Hydralazine can induce antineutrophil cytoplasmic antibody-associated vasculitis due to its auto-immunogenic capability and one of the
Ahmad Al-Abdouh   +4 more
doaj   +1 more source

Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial [version 2; peer review: 2 approved]

open access: yesF1000Research, 2023
Background: Preeclampsia is a highly prevalent disease among pregnant women. In the event of hypertensive emergency, nifedipine, labetalol, and hydralazine are assigned as first-line therapies in preeclampsia.
Maya Savira   +3 more
doaj   +1 more source

New Insights Into Diffuse Sclerosing Osteomyelitis: Is There a Role of ANA and Vitamin B6?

open access: yesOral Diseases, EarlyView.
ABSTRACT Object Diffuse sclerosing osteomyelitis is a poorly understood chronic disease, which appears predominantly in the mandible. Female patients are more often affected than men. DSO is an ultra‐rare disease and incidence is unknown; diagnosis can be very challenging; pathogenesis is poorly understood.
Katharina Theresa Obermeier   +6 more
wiley   +1 more source

A case of hydralazine-induced bullous pemphigoid

open access: yesAboutOpen
Introduction: Hydralazine-induced bullous pemphigoid (BP) is a rare adverse drug reaction where the medication may act to trigger an autoimmune response against proteins in the dermal-epidermal junction (DEJ).
Paul Zammit
doaj   +1 more source

Home - About - Disclaimer - Privacy